Using our defined concentration cutoffs, we were able to differentiate DSAD from DS in the KCL cohort (AUC = 0.91) and demonstrate that all DSAD patients exhibited abnormal plasma NfL when applying cutoffs. The gene discussed is NEFL; the disease is Dravet syndrome.